Does PAZOPANIB Cause Renal cell carcinoma? 244 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 244 reports of Renal cell carcinoma have been filed in association with PAZOPANIB (Pazopanib). This represents 1.2% of all adverse event reports for PAZOPANIB.
244
Reports of Renal cell carcinoma with PAZOPANIB
1.2%
of all PAZOPANIB reports
104
Deaths
72
Hospitalizations
How Dangerous Is Renal cell carcinoma From PAZOPANIB?
Of the 244 reports, 104 (42.6%) resulted in death, 72 (29.5%) required hospitalization, and 3 (1.2%) were considered life-threatening.
Is Renal cell carcinoma Listed in the Official Label?
Yes, Renal cell carcinoma is listed as a known adverse reaction in the official FDA drug label for PAZOPANIB.
What Other Side Effects Does PAZOPANIB Cause?
Death (3,767)
Diarrhoea (2,907)
Fatigue (1,883)
Nausea (1,879)
Malignant neoplasm progression (1,471)
Drug ineffective (1,135)
Decreased appetite (1,116)
Vomiting (1,072)
Hypertension (1,004)
Malaise (764)
What Other Drugs Cause Renal cell carcinoma?
CABOZANTINIB S-MALATE (451)
SUNITINIB MALATE (361)
AXITINIB (154)
RANITIDINE (143)
EVEROLIMUS (130)
SORAFENIB (118)
METHOTREXATE (116)
ADALIMUMAB (105)
PREDNISONE (101)
TACROLIMUS (98)
Which PAZOPANIB Alternatives Have Lower Renal cell carcinoma Risk?
PAZOPANIB vs PEANUT
PAZOPANIB vs PEG INTERFERON
PAZOPANIB vs PEG-INTERFERON ALFA 2A
PAZOPANIB vs PEGASPARGASE
PAZOPANIB vs PEGASYS